Loading the company…
Loading the company…
Families: Peripheral arterial intervention.
All companies · Product and company coverage
In the last ten years FDA made 8 decisions for Eximo Medical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2023 (2). The latest was on 2026-04-10.
| Family | Decisions on record |
|---|---|
| Peripheral arterial intervention | 8 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-04-10 | 510(k) | K260244 | Auryon Atherectomy System |
| 2024-06-27 | 510(k) | K241553 | Auryon Atherectomy Catheter 1.7mm; Auryon Atherectomy Catheter 1.7mm, Hydrophilic Coating |
| 2023-12-15 | 510(k) | K233668 | Auryon Atherectomy Catheter 1.5 mm XL, Hydrophilic Coating (EXM-4010-H000), Auryon Atherectomy Catheter 0.9 mm XL, Hydrophilic Coating (EXM-4011-H000), Auryon Atherectomy Catheter 1.5 mm XL (EXM -4010-0000), Auryon Atherectomy Catheter 0.9 mm XL (EXM-4011-0000) |
| 2023-06-09 | 510(k) | K230709 |
| Auryon Atherectomy System |
| 2022-09-26 | 510(k) | K220116 | Auryon Atherectomy Catheters |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Eximo Medical.